Search Results 441-450 of 17103 for immunitylaughter
The purpose of this study is to determine whether oral inosine dosed to moderately elevate serum urate (from ≤5.7 mg/dL to 7.1-8.0 mg/dL) over 2 years slows ...
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to match ...
Mayo Clinic researchers have published an extensive number of publications related to brain arteriovenous malformations. Learn more about research in neurology ...
About this study. This is a Phase 0 clinical trial to evaluate a twinkling biopsy marker (Patent Application Title: Non-Metallic Ultrasound-Detectable ...
Mayo Clinic researcher Fergus Couch, Ph.D., has spent his career studying inherited breast cancer and cancer genetics. Early on, he saw that many families lived ...
This study is designed to determine if point-of-care washing of allogeneic Leukocyte-Reduced Red Blood Cells reduces pulmonary complications when compared to ...
This rare neurological syndrome that's often caused by Alzheimer's disease affects vision and coordination.
ROCHESTER, Minn. — Mayo Clinic Comprehensive Cancer Center researchers will present their latest radiation oncology findings at the 2025 American Society for ...
ROCHESTER, Minn. — At Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs of a genetic heart ...
About this study. This randomized phase II trial is for medically inoperable early stage non-small cell lung cancer (NSCLC) patients.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.